First Mold is Moving its Prototype Division and Expanding Production Capacity

First Mold, an injection molding and rapid tooling specialist, is moving its prototype division closer to its Gangkou Industrial Park facility to solve problems related to production inefficiencies. ZHONGSHAN, China, Sept. 23, 2025 /PRNewswire/ — First Mold is a leader in precision plastic parts manufacturing and rapid prototyping in China. In 2010, the company opened its […]

Neuromod Advance Multiple Regulatory Approvals to Expedite Global Availability of Lenire

MDSAP certification is an essential milestone towards commercialisation of the Lenire tinnitus treatment device in Australia and Canada. Following MDSAP certification, Neuromod Devices have secured regulatory approval for Lenire from both Australia’s Therapeutic Goods Administration (TGA) and Health Canada. MDR certification supports the continued availability of Lenire in the European market and enables further availability […]

2025 World Manufacturing Convention Scheduled for September 20-23 in Hefei, Anhui

HEFEI, China, Sept. 22, 2025 /PRNewswire/ — The World Manufacturing Convention (WMC) is an internationally recognized gathering endorsed by the State Council to advance China’s diplomatic initiatives and promote Anhui’s outreach and collaboration with global stakeholders. Scheduled for September 20–23 in Hefei, Anhui Province, this year’s convention will focus on the theme “Intelligent Manufacturing for […]

Unstoppable Africa 2025: Africa’s AI Ambitions and Digital Future Go Global

Global Africa Business Initiative highlights groundbreaking projects shaping Africa’s digital and financial future NEW YORK, Sept. 22, 2025 /PRNewswire/ — Major projects and initiatives that are set to position Africa at the heart of global innovation, notably the expansion of the continent’s AI infrastructure, were announced today at Unstoppable Africa 2025 in New York as […]

Finloop Launches CashPro Backed by BNY Investments’ Liquidity Platform

HONG KONG, Sept. 22, 2025 /PRNewswire/ — Finloop Finance Technology Holding Limited, along with its subsidiaries (“Finloop”), an AI-driven global one-stop Web5 (Web2+Web3) wealth technology platform incubated by Fosun Wealth Holdings under Fosun, today announced the launch of “CashPro,” a pioneering instant liquidity management solution for both retail and institutional clients in Hong Kong. This […]

WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year

SHANGHAI, Sept. 23, 2025 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the company has been recognized by FTSE Russell for outstanding sustainability performance. The FTSE4Good Index Series, […]

2025 World Manufacturing Convention Scheduled for September 20-23 in Hefei, Anhui

HEFEI, China, Sept. 23, 2025 /PRNewswire/ — The World Manufacturing Convention (WMC) is an internationally recognized gathering endorsed by the State Council to advance China’s diplomatic initiatives and promote Anhui’s outreach and collaboration with global stakeholders. Scheduled for September 20–23 in Hefei, Anhui Province, this year’s convention will focus on the theme “Intelligent Manufacturing for […]

Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation – DBI

NEW YORK, Sept. 22, 2025 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that Designer Brands may have issued materially misleading business information to the investing public. So What: If you purchased Designer […]

Kelun-Biotech’s New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC

CHENGDU, China, Sept. 22, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company“) announced that a new drug application (NDA) for the Company’s small molecule rearranged during transfection (RET) kinase inhibitor A400 (also known as EP0031) was accepted for review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China for the treatment […]